Vol 80, No 3 (2022)
Clinical vignette
Published online: 2022-02-02

open access

Page views 5104
Article views/downloads 589
Get Citation

Connect on Social Media

Connect on Social Media

Transcatheter tricuspid valve-in-valve replacement due to severe bioprosthesis dysfunction in a patient with endocardial leads

Karolina Plaskota1, Marcin Demkow2, Ilona Michałowska3, Maciej Sterliński4, Mirosław Kowalski1, Piotr Hoffman1
Pubmed: 35113995
Kardiol Pol 2022;80(3):372-373.

Abstract

Not available

References

  1. Sanon S, Cabalka AK, Babaliaros V, et al. Transcatheter tricuspid valve-in-valve and valve-in-ring implantation for degenerated surgical prosthesis. JACC Cardiovasc Interv. 2019; 12(15): 1403–1412.
  2. Dannenberg V, Donà C, Koschutnik M, et al. Transcatheter treatment by valve-in-valve and valve-in-ring implantation for prosthetic tricuspid valve dysfunction. Wien Klin Wochenschr. 2021; 133(15-16): 780–785.
  3. Eleid MF, Asirvatham SJ, Cabalka AK, et al. Transcatheter tricuspid valve-in-valve in patients with transvalvular device leads. Catheter Cardiovasc Interv. 2016; 87(4): E160–E165.
  4. Demir OM, Regazzoli D, Mangieri A, et al. Transcatheter tricuspid valve replacement: principles and design. Front Cardiovasc Med. 2018; 5: 129.
  5. Loyalka P, Nascimbene A, Metz B, et al. Transcatheter tricuspid valve-in-valve replacement with an edwards Sapien 3 valve. Tex Heart Inst J. 2017; 44(3): 209–213.